HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly.

AbstractBACKGROUND:
Despite the wide spectrum of adenoma behavior in patients with acromegaly, the ability of most pathological markers to predict clinical and radiological behavior remains controversial. The authors sought to comprehensively examine clinical and radiological correlates of growth hormone (GH)-secreting pituitary adenomas with regard to several commonly used immunocytochemical techniques in patients undergoing transsphenoidal surgery for acromegaly.
METHOD:
We performed a retrospective review of histopathological findings in 101 surgically resected GH adenomas. Tumors were assessed radiologically for different patterns of extension. Each tumor specimen was subject to immunocytochemical analysis, including assessments of granulation patterns, MIB-1 labeling indices, prolactin cosecretion, p53 expression and mitotic activity. Endocrinological outcome was assessed in 93 patients, with remission defined by the 2010 consensus criteria.
RESULTS:
Most tumors were macroadenomas and almost half were invasive. When compared to densely granulated tumors, sparsely granulated adenomas were associated with a younger age at presentation, higher preoperative IGF-1 levels, elevated MIB-1 index and pure GH immunostaining, but did not differ significantly in terms of extrasellar invasion or outcome. Increased mitotic activity and p53 expression were also associated with higher proliferation indices and a younger age at presentation. Mixed GH/prolactin tumors demonstrated significantly higher remission rates, independent of variations in extrasellar growth. MIB-1 indices did not correlate with the preoperative GH/IGF-1 levels, adenoma size or Knosp grade.
CONCLUSION:
The pathobiology of acromegaly is complex, and the clinicoradiological significance of subtyping on the basis of the markers employed in this study is debatable. Further investigation of newer molecular markers is warranted.
AuthorsSauradeep Sarkar, Ari George Chacko, Geeta Chacko
JournalActa neurochirurgica (Acta Neurochir (Wien)) Vol. 156 Issue 12 Pg. 2221-30; discussion 2230 (Dec 2014) ISSN: 0942-0940 [Electronic] Austria
PMID25238988 (Publication Type: Journal Article)
Chemical References
  • Ki-67 Antigen
  • Tumor Suppressor Protein p53
  • Insulin-Like Growth Factor I
Topics
  • Acromegaly (complications)
  • Adenoma (complications, diagnosis, pathology, surgery)
  • Adult
  • Female
  • Growth Hormone-Secreting Pituitary Adenoma (complications, diagnosis, pathology, surgery)
  • Humans
  • Insulin-Like Growth Factor I (metabolism)
  • Ki-67 Antigen (genetics, metabolism)
  • Male
  • Middle Aged
  • Mitotic Index
  • Retrospective Studies
  • Treatment Outcome
  • Tumor Suppressor Protein p53 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: